Jose Vicente
Jose Vicente
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Verified email at fda.hhs.gov
Title
Cited by
Cited by
Year
Differentiating Drug‐Induced Multichannel Block on the Electrocardiogram: Randomized Study of Dofetilide, Quinidine, Ranolazine, and Verapamil
L Johannesen, J Vicente, JW Mason, C Sanabria, K Waite‐Labott, ...
Clinical Pharmacology & Therapeutics 96 (5), 549-558, 2014
1602014
An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel
WJ Crumb Jr, J Vicente, L Johannesen, DG Strauss
Journal of pharmacological and toxicological methods 81, 251-262, 2016
1262016
Drowsiness detection using heart rate variability
J Vicente, P Laguna, A Bartra, R Bailón
Medical & biological engineering & computing 54 (6), 927-937, 2016
1252016
Comprehensive translational assessment of human-induced pluripotent stem cell derived cardiomyocytes for evaluating drug-induced arrhythmias
K Blinova, J Stohlman, J Vicente, D Chan, L Johannesen, ...
Toxicological Sciences 155 (1), 234-247, 2016
1042016
Comprehensive T wave Morphology Assessment in a Randomized Clinical Study of Dofetilide, Quinidine, Ranolazine, and Verapamil
J Vicente, L Johannesen, JW Mason, WJ Crumb, E Pueyo, N Stockbridge, ...
Journal of the American Heart Association 4 (4), e001615, 2015
952015
Late sodium current block for drug‐induced long QT syndrome: Results from a prospective clinical trial
L Johannesen, J Vicente, JW Mason, C Erato, C Sanabria, K Waite‐Labott, ...
Clinical Pharmacology & Therapeutics 99 (2), 214-223, 2016
872016
Improving the Assessment of Heart Toxicity for All New Drugs through Translational Regulatory Science
L Johannesen, J Vicente, RA Gray, L Galeotti, Z Loring, CE Garnett, ...
Clinical Pharmacology & Therapeutics 95 (5), 501-508, 2014
662014
Detection of driver's drowsiness by means of HRV analysis
J Vicente, P Laguna, A Bartra, R Bailón
2011 Computing in Cardiology, 89-92, 2011
572011
Mechanistic Model‐Informed Proarrhythmic Risk Assessment of Drugs: Review of the “CiPA” Initiative and Design of a Prospective Clinical Validation Study
J Vicente, R Zusterzeel, L Johannesen, J Mason, P Sager, V Patel, ...
Clinical Pharmacology & Therapeutics 103 (1), 54-66, 2018
532018
Common Genetic Variant Risk Score is Associated with Drug-Induced QT Prolongation and Torsade de Pointes Risk: A Pilot Study
DG Strauss, J Vicente, L Johannesen, K Blinova, JW Mason, P Weeke, ...
Circulation, 2017
522017
Mechanisms of sex and age differences in ventricular repolarization in humans
J Vicente, L Johannesen, L Galeotti, DG Strauss
American heart journal 168 (5), 749-756. e3, 2014
472014
Electrocardiographic Biomarkers for Detection of Drug-Induced Late Sodium Current Block
J Vicente, L Johannesen, M Hosseini, JW Mason, PT Sager, E Pueyo, ...
PLOS ONE 11 (12), e0163619, 2016
322016
Automated Algorithm for J-Tpeak and Tpeak-Tend Assessment of Drug-Induced Proarrhythmia Risk
L Johannesen, J Vicente, M Hosseini, DG Strauss
PLOS ONE 11 (12), e0166925, 2016
272016
Comprehensive in vitro proarrhythmia assay (cipa) update from a cardiac safety research consortium/health and environmental sciences institute/fda meeting
DG Strauss, G Gintant, Z Li, W Wu, K Blinova, J Vicente, JR Turner, ...
Therapeutic innovation & regulatory science 53 (4), 519-525, 2019
262019
Evolving regulatory paradigm for proarrhythmic risk assessment for new drugs
J Vicente, N Stockbridge, DG Strauss
Journal of Electrocardiology 49 (6), 837-842, 2016
252016
TDR pressure cell for monitoring water content retention and bulk electrical conductivity curves in undisturbed soil samples
D Moret‐Fernández, J Vicente, B Latorre, F Lera, C Castañeda, MV López, ...
Hydrological Processes 26 (2), 246-254, 2012
232012
Assessing ECG signal quality indices to discriminate ECGs with artefacts from pathologically different arrhythmic ECGs
C Daluwatte, L Johannesen, L Galeotti, J Vicente, DG Strauss, CG Scully
Physiological Measurement 37 (8), 1370, 2016
202016
Assessment of Multi‐Ion Channel Block in a Phase I Randomized Study Design: Results of the Ci PA Phase I ECG Biomarker Validation Study
J Vicente, R Zusterzeel, L Johannesen, R Ochoa‐Jimenez, JW Mason, ...
Clinical Pharmacology & Therapeutics 105 (4), 943-953, 2019
182019
ECGlab: User friendly ECG/VCG analysis tool for research environments
J Vicente, L Johannesen, L Galeotti, DG Strauss
Computing in Cardiology 2013, 775-778, 2013
182013
Ecglib: Library for processing electrocardiograms
L Johannesen, J Vicente, L Galeotti, DG Strauss
Computing in Cardiology Conference (CinC), 2013, 951-954, 2013
162013
The system can't perform the operation now. Try again later.
Articles 1–20